PT96178A - Metodo para a utilizacao de naftoxazinas no tratamento de condicoes associadas com a esquemia cerebral - Google Patents

Metodo para a utilizacao de naftoxazinas no tratamento de condicoes associadas com a esquemia cerebral

Info

Publication number
PT96178A
PT96178A PT96178A PT9617890A PT96178A PT 96178 A PT96178 A PT 96178A PT 96178 A PT96178 A PT 96178A PT 9617890 A PT9617890 A PT 9617890A PT 96178 A PT96178 A PT 96178A
Authority
PT
Portugal
Prior art keywords
cerebral
treatment
conditions associated
naftoxazins
scheme
Prior art date
Application number
PT96178A
Other languages
English (en)
Other versions
PT96178B (pt
Inventor
Joachim Nozulak
Andre Sauter
Jean-Marie Vigouret
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898928316A external-priority patent/GB8928316D0/en
Priority claimed from DE19904003262 external-priority patent/DE4003262A1/de
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT96178A publication Critical patent/PT96178A/pt
Publication of PT96178B publication Critical patent/PT96178B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
PT96178A 1989-12-14 1990-12-13 Metodo para a utilizacao de naftoxazinas no tratamento de condicoes associadas com a esquemia cerebral PT96178B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898928316A GB8928316D0 (en) 1989-12-14 1989-12-14 Improvements in or relating to organic compounds
DE19904003262 DE4003262A1 (de) 1990-02-03 1990-02-03 Neues naphthoxazin, seine herstellung und verwendung

Publications (2)

Publication Number Publication Date
PT96178A true PT96178A (pt) 1991-09-30
PT96178B PT96178B (pt) 1998-04-30

Family

ID=25889734

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96178A PT96178B (pt) 1989-12-14 1990-12-13 Metodo para a utilizacao de naftoxazinas no tratamento de condicoes associadas com a esquemia cerebral

Country Status (14)

Country Link
US (1) US5190941A (pt)
EP (1) EP0433239B1 (pt)
JP (1) JPH0825880B2 (pt)
KR (1) KR0182276B1 (pt)
AT (1) ATE113040T1 (pt)
AU (1) AU639512B2 (pt)
CA (1) CA2032132A1 (pt)
CY (1) CY2065B1 (pt)
DE (1) DE69013476T2 (pt)
DK (1) DK0433239T3 (pt)
ES (1) ES2063328T3 (pt)
HU (1) HU214591B (pt)
IE (1) IE66143B1 (pt)
PT (1) PT96178B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0647137T3 (da) * 1992-06-22 2008-12-08 State Of Oregon Through Oregon Glycinreceptorantagonister og anvendelse deraf
DE4329776A1 (de) * 1993-09-03 1995-03-09 Sandoz Ag Naphthoxazine, ihre Herstellung und Verwendung
AU2009303389B2 (en) 2008-10-17 2014-10-16 Wisconsin Alumni Research Foundation Method of making biologically active alpha-beta peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540691A (en) * 1984-04-13 1985-09-10 Nelson Research & Development Co. Dopamine agonists and use thereof
NL194166C (nl) * 1984-06-12 2001-08-03 Novartis Ag Naftoxazinen en bereiding en toepassing daarvan. Hexahydronaft[2,3-b]-1,4-oxazinen en farmaceutische preparaten die ze bevatten.
EP0233728A1 (en) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazine derivatives their production and use

Also Published As

Publication number Publication date
KR910011261A (ko) 1991-08-07
IE66143B1 (en) 1995-12-13
HU908017D0 (en) 1991-06-28
HK1000244A1 (en) 1998-02-13
AU6797590A (en) 1991-06-20
CA2032132A1 (en) 1991-06-15
HUT57749A (en) 1991-12-30
DE69013476D1 (de) 1994-11-24
CY2065B1 (en) 1998-06-12
KR0182276B1 (ko) 1999-05-01
JPH03271223A (ja) 1991-12-03
AU639512B2 (en) 1993-07-29
US5190941A (en) 1993-03-02
HU214591B (hu) 1998-04-28
DE69013476T2 (de) 1995-05-04
EP0433239B1 (en) 1994-10-19
IE904497A1 (en) 1991-06-19
ATE113040T1 (de) 1994-11-15
JPH0825880B2 (ja) 1996-03-13
EP0433239A1 (en) 1991-06-19
DK0433239T3 (da) 1995-01-16
PT96178B (pt) 1998-04-30
ES2063328T3 (es) 1995-01-01

Similar Documents

Publication Publication Date Title
ATE45942T1 (de) Diarylacetylene, ihre herstellung und verwendung.
LV11175A (lv) Jauni sulfonilaminopirimidini
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
PT97796A (pt) Processo para a preparacao de piperidinas substituidas
DE69424009D1 (de) Verwendung von (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidinacetamid zur Herstellung eines Medikaments zur Behandlung von Angst
AU7736191A (en) Oxazolidinones
PT80820B (pt) Processo para a preparacao de derivados de 1,3-propilidenodifosfonato 2-substituidos
DK0652208T3 (da) Phenylalkan(en)syrer
BR9404776A (pt) Processo para a preparação de 2,2-difluorceteno silil acetais e processo para a preparação de ésteres de ácido alfa,alfa-diflúor-beta-sililóxi-1,3-dioxolano-4-propanóico
PT97259A (pt) Processo para a estabilizacao de isotiazolonas com fenoxialcanois
BR9200627A (pt) Processo para a preparacao de um composto e composto obtido
PT545511E (pt) Processo para a preparacao de tetraazamacrociclos mono-n-substituidos
BR1100207A (pt) Processo para a preparação de derivados de hexa-hidroazepina
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
MX9205724A (es) Procedimiento para la copulacion reductora con pinacol, selectiva para diastereoisomeros, de a-aminoaldehidos homoquirales
PT88355A (pt) Processo para a conversao da estrutura cristalina polimorfica do cloridrato de buspirona
BR9400016A (pt) Processo para preparação de compostos, e compostos
HUT71512A (en) N-(3-chlorophenyl)-piperazine derivatives for producing alkyl-trazodon derivatives and process for producing them
CY2065B1 (en) Use of naphthoxazines
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
PT89029A (pt) Processo para a preparacao de novos derivados substituidos de 20,21-dinoreburnamenina
DK0643055T3 (da) Fremgangsmåde til fremstilling af 5-amino-2,2-dialkyl-1,3-dioxaner
DE3871862D1 (de) Thiophenverbindungen und deren herstellung.
SE8700566L (sv) Tetracykliska kinazolinoner

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910430

FG3A Patent granted, date of granting

Effective date: 19980113

PC3A Transfer or assignment

Free format text: 980209 NOVARTIS AG CH